The largest database of trusted experimental protocols

Percp5

Manufactured by BioLegend
Sourced in United States, Denmark

PerCP5.5 is a fluorescent dye used in flow cytometry applications. It has an excitation wavelength of 488 nm and an emission wavelength of 675 nm, making it suitable for detection in the peridinin-chlorophyll protein complex (PerCP) channel. The dye can be used to label antibodies or other biomolecules for analysis on flow cytometers.

Automatically generated - may contain errors

5 protocols using percp5

1

Macrophage Marker Analysis by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
To measure macrophage marker levels in primary TM and corticosterone-polarized BMDM flow cytometry was used. In brief, 1 × 106 cells were washed twice with washing buffer (1% BSA in PBS) and incubated with an anti-mouse CD16/32 antibody (553142, BD Biosciences, San Jose, USA) for 10 min. Then, anti-mouse CD45 (103128, Biolegend, APC-R700, 1:100), F4/80 (123118, Biolegend, APC-cy7, 1:100), CD11b (553310, BD, FITC, 1:100), and CD206 (141716, Biolegend, Percp 5.5, 1:100) antibodies were used to identify the macrophage populations. After incubating the cells with CD45, CD11b, F4/80 for 30 min on ice, cells were washed with PBS 1% w/v BSA, fixed, permeabilized, and labeled with anti-CD206 at 4°C for 30 minutes. Then cells were washed and re-suspended in washing buffer. Flow cytometric analysis was performed by using a FACS AriaII (BD) and data were analyzed with FlowJo software version X (Tree Star, Ashland, OR, USA).
+ Open protocol
+ Expand
2

Monocyte Subset Identification and iMac Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monocyte subsets were analyzed by gating for CD14 (PacificBlue; BD Biosciences) and CD16 (PerCPCy5.5; BD Biosciences) in order to distinguish the three subsets of classical/inflammatory (HLA-DR+CD16-CD14+), intermediate (HLA-DR+CD16+CD14+) and nonclassical (HLA-DR+CD16++CD14-) monocytes, as described earlier (27 (link)). The gating strategy is depicted in Figure S1F. Sorting of monocyte subsets was performed on a MoFlo Astrios EQ (Beckman Coulter) cell sorter. To characterize iMacs, cells were stained for CD206 (APC, eBioscience), CD45 (PE Beckman-Coulter), CD33 (PerCP5.5, Biolegend), CD14 (FITC, Beckman-Coulter), CD11b (PE BD), or with the corresponding isotype controls and analyzed on an Accuri C6 flow cytometer (BD Bioscience).
+ Open protocol
+ Expand
3

Phagocytosis Assay for Dendritic Cell-Mediated Killing of NSCLC Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
After in vitro generation of DCs, NCI-H1975, A549 and NCI-H1650 cells were labelled with PKH67, a green fluorescent membrane dye (Sigma Aldrich, MIDI67), prior to plating them out on day 3. NSCLC cells were treated with chemotherapy on day 4. On day 5, immature DCs were stained with cytoplasmic violet-fluorescent CellTracker Violet BMQC dye (Invitrogen, C10094) and effector (E) and target (T) cells were placed in coculture at a 1:1 (E:T) ratio. Supernatant (SN) was stored (−20 °C), cells were collected and immediately used for flowcytometric detection of DC maturation markers and phagocytosis on day 7. Cells were stained with CD80-PerCP5.5 (Biolegend, 400150) and CD86-PE-Cy7 (BD Biosciences, 557872) to assess DC maturation (Violet+ population). Isotype controls (PerCP5.5, Biolegend, 305232; PE-Cy7, BD Biosciences, 557872) were included to subtract aspecific signals from measured fluorescence intensity. Phagocytosis of NSCLC cells was assessed by gating on the PKH67+Violet+ population, as previously described [35 (link)]. Acquisition was performed on a FACSAria II (BD Biosciences). Data analysis was performed using FlowJo v10.1 software (TreeStar).
+ Open protocol
+ Expand
4

PBMC-derived CD14+ cell differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The in vitro cell differentiation assay on PBMC-derived CD14+ cells using the same protocol as the assay on the U937 cells. Considering the limited number of sorted cells, this assay was performed using early and end-stage SF samples only. Thus, PBMC-derived CD14+ cells were induced using SFs of KL grade II and IV. After 48 h of SF treatment, the induced cells were analyzed using a flow cytometry panel including cell surface markers like CD11C (FITC, BioLegend, San Diego, CA, USA), CD86 (PECy7, BioLegend, San Diego, CA, USA), and CD163 (PerCP 5.5, BioLegend, San Diego, CA, USA) as per the manufacturer’s instructions. The cell acquisition and data analysis were the same as the assay on the U937 cells. These flow cytometry experiments were performed in triplicate and repeated three times. In total, six OA SFs (three SFs of grade II and three SFs of grade IV) were used for this set of experiments.
+ Open protocol
+ Expand
5

Flow Cytometry Analysis of Immune Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
The monoclonal antibodies used were purchased from eBioscience (San Diego, CA, USA) BioLegend (London, UK) or BD (San Diego, CA, USA). Flow cytometric analysis or cell sorting was performed on an LSR-Fortessa or a FACS-Aria-III, respectively (both BD). Antibodies used for flow cytometry: T-cells: 53-6.7, anti-CD8 (25-0081-82, eBioscience); RM 4-5, anti-CD4 (45-0042-82, eBioscience); 3C7, anti-CD25 (12-0251-83, eBioscience); B-cells: RA3-6B2, anti-B220 (103224, Biolegend); 1B11, anti-CD43 (121204, Biolegend); 2B8, anti–c-Kit (105813, Biolegend); II/41, anti-IgM (406509, Biolegend); 11/26C, anti-IgD (12-5993-83, eBioscience); 6D5, anti-CD19 (115533, Biolegend); myeloid cells: RB6-8C5, anti–Gr-1 (108404, Biolegend); S7, MI/70, anti–Mac-1 (17-0112-83, eBioscience). Biotinylated antibodies were detected using streptavidin-RPE (DAKO, Glostrup, Denmark) or streptavidin coupled to PE-Cy7, APC, APC-Cy7 or PerCP5.5 (BioLegend or eBioscience).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!